fda clearance
-
Hospitals
FDA Clears First Nanotechnology Peek Devices for Spinal Intervertebral Fusion
July 17, 2018 NASHUA, N.H.–(BUSINESS WIRE)–Vallum Corporation, a medical device company, today announced that it has received clearance from the…
Read More » -
Hospitals
FDA Clears The Way: Lipogems’ Receives FDA Clearance For Microfragmented Adipose Tissue System Utilizing Body’s Own Fat To Support Tissue Repair In Orthopaedic And Arthroscopic Surgeries
NORCROSS, Ga., July 5, 2018 /PRNewswire/ — Lipogems, a leader in medical technologies for orthopaedic physicians, announced U.S. Food and Drug Administration (FDA)…
Read More » -
Recon
Medacta Launches Short Humeral Diaphysis for the Medacta Shoulder System at the San Diego Shoulder Institute’s Annual Shoulder Course
June 18, 2018 SAN DIEGO–(BUSINESS WIRE)–Medacta® International, the privately held family-owned global leader in the design of innovative joint replacement and…
Read More » -
Hospitals
Arthrosurface Gains FDA Clearance of OVOMotion™ Shoulder Arthroplasty System
FRANKLIN, Mass., April 18, 2018 /PRNewswire/ — Arthrosurface® announced today that The Company received FDA 510(k) Clearance to market the OVOMotion™ Shoulder Arthroplasty System.…
Read More » -
Hospitals
Ceterix Orthopaedics Announces FDA Clearance of the NovoStitch Pro Meniscal Repair System
April 16, 2018 FREMONT, Calif.–(BUSINESS WIRE)–Ceterix® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today…
Read More » -
Hospitals
CTL Wins FDA Approval for Seurat Universal Pedicle Screw
DALLAS, TX / ACCESSWIRE / March 29, 2018 / CTL Medical Corporation, a Dallas-based medical device manufacturing and service company, has…
Read More » -
Hospitals
Amedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion Device
SALT LAKE CITY, UT, March 06, 2018 (GLOBE NEWSWIRE) — Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops…
Read More » -
Biologics
FDA Clears Bone Scaffold ReBOSSIS® for New Indication
GEORGETOWN, TEXAS (PRWEB) JANUARY 11, 2018 Last month, the Food and Drug Administration cleared ReBOSSIS®, the only biosynthetic bone scaffold with…
Read More »